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Men who have sex with men
Sexual behavior change
Sexual behavior trajectories
A B S T R A C T
Changes in sexual risk behavior over the life course in men who have sex with men (MSM) can influence
population-level intervention efficacy. Our objective was to investigate the impact of incorporating sexual tra-
jectories describing long-term changes in risk levels on the reduction in HIV prevalence by pre-exposure pro-
phylaxis (PrEP) among MSM. Based on the Amsterdam Cohort Study data, we developed two models of HIV
transmission in a population stratified by sexual behavior. In the first model, individuals were stratified into low,
medium and high risk levels and did not change their risk levels. The second model had the same stratification
but incorporated additionally three types of sexual behavior trajectories. The models assumed universal anti-
retroviral treatment of HIV+ MSM, and PrEP use by high risk HIV− MSM. We computed the relative reduction in
HIV prevalence in both models for annual PrEP uptakes of 10% to 80% at different time points after PrEP
introduction. We then investigated the impact of sexual trajectories on the effectiveness of PrEP intervention.
The impact of sexual trajectories on the overall prevalence and prevalence in individuals at low, medium and
high risk levels varied with PrEP uptake and time after PrEP introduction. Compared to the model without sexual
trajectories, the model with trajectories predicted a higher impact of PrEP on the overall prevalence, and on the
prevalence among the medium and high risk individuals. In low risk individuals, there was more reduction in
prevalence during the first 15 years of PrEP intervention if sexual trajectories were not incorporated in the
model. After that point, at low risk level there was more reduction in the model with trajectories. In conclusion,
our study predicts that sexual trajectories increase the estimated impact of PrEP on reducing HIV prevalence
when compared to a population where risk levels do not change.
1. Introduction
In the Netherlands, men who have sex with men (MSM) continue to
be the group most affected by the HIV epidemic. Despite the increase of
antiretroviral treatment (ART) uptake and shortening of time between
infection and diagnosis, in 2016 68% of new HIV diagnoses were in
MSM (van Sighem et al., 2017).
A recent systematic review of European studies on HIV prevention
interventions among MSM has shown the most effective interventions
to be condom use, peer outreach, peer-led groups, universal ART cov-
erage and treatment as prevention (Strömdahl et al., 2015). A further
reduction in HIV transmission in this population is expected to occur
after the rollout of pre-exposure prophylaxis (PrEP) (Reyniers et al.,
2017; Hoornenborg et al., 2017). PrEP was shown to be highly effective
in preventing HIV acquisition among MSM in several trials (e.g.
McCormack et al., 2016; Molina et al., 2015) and clinical practice
studies (e.g. Liu et al., 2016; Volk et al., 2015). In the Netherlands, a
prospective, longitudinal, open-label demonstration study named the
Amsterdam pre-exposure prophylaxis (AMPrEP) project was initiated to
assess the uptake and acceptability of daily versus event-driven PrEP
among MSM, as part of a comprehensive HIV reduction package offered
at a large sexually transmitted infections clinic (Hoornenborg et al.,
2018a).
Several modelling studies demonstrated a positive effect of PrEP on
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the reduction in HIV transmission among MSM. Punyacharoensin and
colleagues (Punyacharoensin et al., 2016) predicted that without PrEP
HIV incidence in MSM in the UK would be unlikely to decrease sub-
stantially by the end of this decade. PrEP was shown to be cost-effective
for HIV prevention among MSM in the Netherlands (Nichols et al.,
2016) and other countries (Schneider et al., 2014; Juusola et al., 2012).
Although the body of literature showing a positive effect of PrEP for
HIV prevention is growing, the real-world effect of nation-wide PrEP
intervention is not evident. One of the difficulties in making such a
prediction is the fact that changes in sexual risk behavior are likely to
occur over time, which might hamper the effectiveness of population-
level interventions. Population-level temporal changes in the behavior
of MSM in the Netherlands since the start of the HIV epidemic have
been well documented (van Griensven et al., 1989; Stolte et al., 2004;
Bezemer et al., 2008, 2010; Jansen et al., 2011; Heijman et al., 2012).
In the AMPrEP study, an increase in condomless anal sex acts with
casual partners was observed over the first 6 months after initiation of
PrEP by the Dutch MSM (Hoornenborg et al., 2018b). Individual het-
erogeneity in sexual behavior of MSM over time has been described by
Romero-Severson et al. (2012, 2015). Recent modelling studies showed
that behavioral heterogeneity due to the number of sexual partners
(Rozhnova et al., 2016) and short-term changes in risk behavior
(sometimes referred to as episodic risk) (Henry and Koopman, 2015)
have a strong influence on the prospects of HIV elimination by test-and-
treat strategies, confirming that individual-level sexual behavior is a
major determinant of population-level intervention efficacy. Our recent
modeling study has shown that PrEP could have a large impact on the
HIV epidemic among MSM in the Netherlands if sexual risk behavior
does not change (Rozhnova et al., 2018). The impact of behavioral
changes on the effectiveness of PrEP intervention has received less at-
tention in the literature, mainly because one needs good quality long-
itudinal data to characterize behavior change among MSM.
Recently our research group (Basten et al., 2018) studied changing
patterns of sexual behavior across the life course in MSM. Using data
from the Amsterdam Cohort Studies on HIV and AIDS (ACS) we iden-
tified three typical trajectories of changing sexual behavior from sexual
debut onwards (Basten et al., 2018). The sexual trajectories aim to
capture long-term changes in sexual behavior within the MSM popu-
lation and not the secular trends in the general MSM population, so that
people with a certain level of risk at sexual debut can increase or de-
crease their risk level over their life course. The changes we focus on in
this study are slow, implying that the average duration of stay at any
risk level is of the order of several years to decades. It is not clear
whether these sexual behavior trajectories may undermine or enhance
the impact of PrEP interventions. Therefore, the objective of this study
was to investigate the impact of long-term changes in sexual risk be-
havior (sexual trajectories) of MSM on the reduction in HIV prevalence
by PrEP in the Netherlands.
2. Material and methods
2.1. Epidemiological data
The long-term sexual behavior trajectories estimated by Basten et al.
(2018) formed the basis of this study. The estimated trajectories were
based on data from the ACS among MSM, which started in 1984 (van
Griensven et al., 1989; Jansen et al., 2011). The ACS is a population-
based open cohort study to investigate the epidemiology, psychosocial
determinants, course of infection and pathogenesis of HIV. At each
biannual visit, MSM are asked to fill in a questionnaire about their
sexual behavior in the past six months and they are tested for HIV and
sexually transmitted infections.
In this study, data was used from 803 HIV-negative MSM who
participated in the ACS between 2007 and 2017, which comprised a
total of 8198 visits. The average number of visits per participant was
10.2 (sd 5.9). A behavioral risk score predictive of HIV acquisition was
developed, which consisted of several behavioral variables including
number of receptive and insertive anal intercourse partners, condom
use and group sex. The detailed information about the risk score can be
found in the Supplementary Material. Subsequently, this risk score was
used to study trajectories of sexual risk behavior from sexual debut with
a man onwards using latent class growth mixture modeling. Three
linear trajectories were identified that describe longitudinal changes in
sexual behavior within the MSM population: a low risk trajectory of low
sexual risk behavior with a small increase over time (90.3% of the
sample); a decreasing risk trajectory (6.5%) with very high levels of
sexual risk behavior during the first years after sexual debut and a
decrease to low risk over time; and an increasing risk trajectory (3.3%)
with low levels of sexual risk behavior in the first years after sexual
debut and a rapid increase over time (see Supplementary Fig. 1 adapted
from Basten et al. (2018)).
Based on these data, we developed two models of HIV transmission
in a population stratified by sexual risk behavior. In the first model, the
MSM population was stratified into three risk levels and individuals did
not change their risk levels throughout their lives. The risk score was
used to define three levels of sexual risk behavior: low risk level (risk
score below 0.75), medium risk level (risk score between 0.75 and 2.5)
and high risk level (risk score above 2.5) (Supplementary Fig. 1). The
population fractions for the three risk levels (l=1, 2, 3) were provided
by calculating the proportion of visits at each risk level over all visits
(Supplementary Table 1).
The second model had the same risk level stratification, but allowed
for long-term changes in risk levels according to the three trajectories
described above. In this model, MSM were stratified according to risk
level (l=1, 2, 3) and the three sexual trajectories (b=1, 2, 3). Visits at
which MSM in the low risk trajectory reported high risk were treated as
if they were visits from MSM in the decreasing risk trajectory. This
resulted in eight different strata (Supplementary Table 1). The initial
population fractions of this model were calculated as the proportions of
visits within each stratum over all visits. The average duration of stay at
each risk level for MSM in the decreasing risk and increasing risk tra-
jectories was based on the estimated growth parameters of the latent
class growth mixture model. We assumed that behavior was stable in
the years that fall outside the estimated trajectories (Supplementary
Table 3). Although on the population level, MSM following the low risk
trajectory always stayed at the low risk level, individual-level data of
MSM in this trajectory showed that they also had periods of higher risk
behavior. Therefore, we allowed MSM in the low risk trajectory to
transit between the low and medium risk levels. To determine these
transition rates we calculated the proportions of MSM in the low risk
trajectory that move from low risk to medium (or high) risk level be-
tween two consecutive biannual visits. Subsequently, biannual rates
were transformed to annual transition rates. Reverse transition rates
were based on the average time that MSM who follow the low risk
trajectory spend at the medium risk (or high risk) level (Supplementary
Table 4).
For both models, risk level specific partner change rates were based
on the average number of reported casual partners with whom they had
unprotected receptive or insertive anal intercourse in the past six
months over all visits at each risk level (Supplementary Table 2). We
multiplied the averages by 1.5 to obtain number of partners per year,
because some partnerships are likely to last more than 6 months (Heijne
et al., 2017). Since sexual behavior data of MSM more than 45 years
after first sexual contact was scarce, the average duration of stay after
sexual debut was set to 45 years in both models.
Table 1 summarizes the parameters estimated from the ACS data as
described in this section.
2.2. Model without sexual trajectories
The model without sexual trajectories is a version of the model in
(Rozhnova et al., 2016) extended to include PrEP (Fig. 1). It assumes
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that an MSM population of size N(t) is stratified into three risk levels of
size Nl(t) with partner change rates cl, l=1, 2, 3. The risk levels re-
present individuals with low (l=1), medium (l=2) and high (l=3)
number of sexual partners. In the model without sexual trajectories we
assume that individuals do not change their risk level during their
lifetime. For risk level l, the population is further stratified according to
HIV and PrEP status into susceptible, Sl(t), susceptible on PrEP, S t( )lP ,
infected, Ilk(t), infected despite taking PrEP, I t( )lkP , and treated, Alk(t),
individuals. HIV infected individuals can be in one of k=1, 2, 3, 4
infection stages: primary infection (k=1), chronic infection (k=2),
and AIDS (k=3, 4). The two AIDS stages differ in infectivity which we
assume to be zero in the latter stage due to severe illness and the ces-
sation of sexual activity. The total population size can be expressed as
= =N t N t( ) ( )l l1
3 , where population size for level l is given by






The dynamics of the model is as follows (see Fig. 1). Individuals at risk
level l enter the sexually active population at rate μN0ql as susceptible,
where μ is the recruitment rate, N0 and ql are the total population size and
population fraction at risk level l. Susceptible MSM take daily PrEP with
rate Klon and drop off PrEP with rate Kl
off . MSM become infected with force
of infection J t( )lP . MSM on PrEP may still get infected but with reduced
force of infection J t( )lP , where (1−Ω) quantifies PrEP effectiveness.
PrEP is fully effective if Ω=0. Ω=1 corresponds to the situation of
complete ineffectiveness because PrEP users get infected with the same
force of infection as non-PrEP users. Infected individuals either progress
through infection stages and die from AIDS with rates ρk (k=1, 2, 3, 4) or
start ART at rate τ in any stage. Individuals on ART progress through four
stages and die with rates γk (k=1, 2, 3, 4) or can stop taking ART due to
virological failure or other reasons with rate φ. The majority of individuals
on PrEP is regularly monitored, that is why we assumed that individuals
infected while on PrEP can only be in the primary stage of infection, IlP1 . A
fraction p∈ [0, 1] of them start taking ART with rate >lP . The re-
maining fraction (1− p) moves into the compartment of HIV infected in-
dividuals in the first stage who did not take PrEP. All individuals leave the
sexually active population at rate μ.
The model is described by a set of differential equations for the
number of individuals in different compartments as follows
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where k=2, 3, 4 and l=1, 2, 3.
The force of infection (per year) at level l is given by
= + +
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The force of infection takes into account that infectivities of un-
treated individuals, hk, depend on infection stage k=1, 2, 3, 4.
Table 1
Behavioral parameters estimated from the ACS data.
Notation Baseline value, unit Description
1/μ 45 year−1 Average duration of sexual activity
cl, l=1, 2, 3 c1= 0.255 year−1
c2= 2.97 year−1
c3= 29.19 year−1
Partner change rates at risk level l
ql, l=1, 2, 3 q1= 0.715
q2= 0.261
q3= 0.024
Initial population fractions at risk level l
ql,b, l=1, 2, 3, b=1 q1,1= 0.006
q2,1= 0.013
q3,1= 0.005
Initial population fractions at risk level l, increasing risk trajectory
ql,b, l=1, 2, 3, b=2 q1,2= 0.015
q2,2= 0.029
q3,2= 0.019
Initial population fractions at risk level l, decreasing risk trajectory
ql,b, l=1, 2, b=3 q1,3= 0.694
q2,3= 0.219
Initial population fractions at risk level l, low risk trajectory
1/ ll b, , b=1 1/α12,1= 10.1 years
1/α23,1= 7.6 years
Average duration of stay at risk level l, increasing risk trajectory
1/αll′,b, b=2 1/α21,2= 15.8 years
1/α32,2= 15.1 years
Average duration of stay at risk level l, decreasing risk trajectory
1/αll′,b, b=3 1/α12,3= 5.618 years Average duration of stay at risk level l, low risk trajectory
1/vll′,b, b=3 1/ν21,3= 1.56 years
Fig. 1. Diagram of the model without sexual trajectories. The upper dia-
gram describes HIV transmission dynamics for individuals at risk level l (l=1,
2, 3). The lower diagram represents an MSM population as stratified by the
number of sexual partners into three risk levels (low, medium and high) where
individuals do not change their risk level during their life course.
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Infectivity of individuals on ART, ϵ, is stage independent. We further
assumed that individuals who get infected despite taking PrEP may
have lower viral loads levels and thus lower infectivity in the primary
stage, ϵP, than individuals who do not take prophylaxis, h1, ϵP≤ h1. The
force of infection depends also on the transmission probability per
partnership, λ, partner change rates, cl (l=1, 2, 3), and mixing be-
tween susceptible MSM at level l and infected MSM at level l′ = 1, 2, 3.
Mixing is described by a matrix with the elements M t( )ll
= +
=
M t c N t
c N t
( ) ( )
( )






where = 1ll if l= l′ and = 0ll otherwise. Mixing parameter ω∈ [0, 1]
allows to change mixing from assortative (ω=0) to proportionate (ω=1).
Values of ω between 0 and 1 correspond to intermediate levels of mixing.
2.3. Model with sexual trajectories
In the model with sexual behavior trajectories MSM can change
their risk level during their lifetime. Motivated by the analysis of the
ACS data we incorporate three types of trajectories (Fig. 2). The in-
creasing risk trajectory is comprised of individuals who increase their
risk level from low to medium to high throughout their life course. The
decreasing risk trajectory is comprised of individuals who decrease
their risk level from high to medium to low throughout their life course.
The low risk trajectory is comprised of the remaining individuals who
switch their risk level between low and medium throughout their life
course. The described transitions represent the baseline scenario of the
model with trajectories. They are shown as solid arrows in Fig. 2. In the
sensitivity analyses, we considered additional transitions between risk
levels which allow individuals to move in the reverse direction along
the trajectories. These additional transitions are shown as dashed ar-
rows in Fig. 2 and are referred to as reverse transitions in the following
text. Except for allowing changes in risk level, the model with sexual
trajectories has the same HIV dynamics as the model without trajec-
tories. In particular, PrEP uptake depends on risk level and is in-
dependent of the sexual trajectory.
The transition rates from risk level l to risk level l′ (l, l′=1, 2, 3) along
trajectory b (b=1, 2, 3) are denoted as ll b, . The reverse transition rates
from risk level l to risk level l′ along trajectory b are denoted as ll b, . As
before, the subscript l stands for risk level: l=1 (low risk level), l=2
(medium risk level), and l=3 (high risk level). The subscript b stands for
sexual trajectory: b=1 (increasing risk trajectory), b=2 (decreasing risk
trajectory), b=3 (low risk trajectory). We denote as Nl,b the number of
individuals at risk level l who belong to sexual trajectory b. For future
comparison with the model without sexual trajectories we note that the
total population size is = =N t N t( ) ( )l l1
3 , where population sizes at level l
are given by = =N t N t( ) ( )l b l b1
3
, . This means that in the model with tra-
jectories we obtain the number of individuals at risk level l by summing
over all trajectories b.
The model equations for the number of susceptible, Sl,b(t), susceptible
on PrEP, S t( )l bP, , infected, Ilk,b(t), infected despite taking PrEP, I t( )l bP1, , and
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where l=1, 2, 3, b=1, 2, 3, k=2, 3, 4, l′= (−1)b, = 0ll b, and = 0ll b,
if l < 1 or l′ < 1 or l > 3 or l′ > 3.
Fig. 2. Diagram of the model with sexual trajectories. The upper diagram
shows HIV transmission dynamics for individuals at risk level l (l=1, 2, 3) and
sexual trajectory b (b=1, 2, 3). For a given l and b this dynamics is the same as
in the model without sexual trajectories (Fig. 1). The lower diagram represents
an MSM population as stratified by the number of sexual partners into three risk
levels (low, medium and high) where individuals exhibit three types of sexual
behavior trajectories (increasing risk trajectory, decreasing risk trajectory and
low risk trajectory). Transitions identifying these sexual trajectories are shown
as solid arrows between different risk levels. Reverse transitions between risk
levels shown as dashed arrows were used only in the sensitivity analyses.
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The force of infection, J t( )lP , is given by Eq. (2),
where population size at risk level l is given by
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, l=1, 2, 3.
2.4. Model parameterisation for HIV infection
The remaining parameters and their baseline values are summarized
in Table 2. The values for initial population size, transition rates be-
tween stages, disease related mortality and infectivity for treated in-
dividuals were taken from our previous work (Rozhnova et al., 2016).
For untreated individuals, we adjusted infectivity and transition rates
between primary and chronic stages according to their estimates in
(Bellan et al., 2015). Since estimates of the degree of assortative mixing
in the population of MSM in the Netherlands are not available, we
considered an intermediate level of mixing.
We presented our results in terms of annual uptake and dropout per-
centages both for PrEP and ART. The annual rates of uptake and dropout
used in the model equations were computed from the expression for the
probability that uptake or dropout event occurs within one year as
= ×percentage [1 exp( rate 1year)]100%. The annual ART dropout
percentage was fixed at 5% for all infection stages, risk levels and trajec-
tories (Rozhnova et al., 2016). ART uptake was uniform for all infection
stages, risk levels and trajectories during all analyses. In the models without
PrEP we varied annual ART uptake percentage between 0% and 100%. In
the models with PrEP, ART uptake percentage was always 30%. This up-
take corresponded to ART coverage of about 80% observed in the Neth-
erlands (van Sighem et al., 2017). Transmission probability per partnership
was chosen so that before ART was initiated the basic reproduction number
in both models was similar and close to its estimates obtained for Western
MSM populations (Kretzschmar et al., 2013).
For consistent PrEP users, its effectiveness is now considered to be
very high (Duwal et al., 2016). In the model PrEP effectiveness was
fixed at 0.95. We considered the scenario where PrEP was taken only by
high risk individuals, setting uptake by individuals with low and
medium risk to zero. The annual PrEP uptake was varied between 0%
and 80%, and average duration of PrEP use was 5 years (Nichols et al.,
2016). Since the majority of individuals on PrEP is regularly monitored,
we assumed that for all individuals who got infected despite using PrEP
annual uptake was 95% (Rozhnova et al., 2018). It is important to note
that although in both models PrEP was taken only by high risk in-
dividuals, in the model with sexual trajectories there could be PrEP
users at medium and low risk levels as well, because this model allowed
for high risk MSM to decrease sexual risk behavior along decreasing risk
trajectory. Estimates of infectivity in the primary stage for PrEP users
have not been obtained but are likely to be lower than for non-PrEP
users. In our study the default value for this parameter was half the
infectivity of non-PrEP users (Rozhnova et al., 2018).
2.5. Model outcome measures
We computed the effective reproduction number, Re, using the next
generation matrix theory (Diekmann et al., 2010; van den Driessche
and Watmough, 2002). Re is defined as the average number of sec-
ondary infections caused by a typical infectious individual in a popu-
lation, where intervention measures are implemented. HIV elimination
occurs if Re < 1.
We numerically solved the model equations for PrEP uptake by high
risk individuals of 10%, 20%, 50% and 80% annually, starting from the
baseline scenario without PrEP. For both models, we quantified the
impact of PrEP on HIV prevalence as the relative reduction in HIV
prevalence. This measure was computed as (1-prevalence after PrEP/
prevalence before PrEP)×100% at several time points during the
course of the epidemic. The time points were 5, 15 and 40 years after
PrEP introduction, and also in the steady state. The steady state was
included to quantify PrEP impact on a long time scale.
Since we were interested in understanding the differences between
the models caused by sexual trajectories, we presented the results in
terms of the absolute difference between the relative reduction in HIV
prevalence in the model with sexual trajectories and the relative re-
duction in HIV prevalence in the model without sexual trajectories. In
what follows, we refer to this quantity as the contribution of sexual
trajectories to impact of PrEP on HIV prevalence. A positive contribu-
tion of sexual trajectories indicates that the model with sexual trajec-
tories predicts a higher impact of PrEP on HIV prevalence. A negative
contribution of sexual trajectories means that PrEP impact on HIV
prevalence is higher for the model without trajectories. Zero contribu-
tion of sexual trajectories indicates that PrEP impact on HIV prevalence
Table 2
HIV infection parameters and their baseline values.
Notation Baseline value, unit Description
ρk ρ1= 1/0.142 year−1
ρ2= 1/8.439 year−1
ρ3= 1/1.184 year−1
Rate of transition from stage k to stage k+1 for untreated individuals (k=1, 2, 3)
ρ4 ρ4= 1/1.316 year−1 HIV related mortality for untreated individuals
γk γ1= 1/8.21 year−1
γ2= 1/54.0 year−1
γ3= 1/2.463 year−1
Rate of transition from stage k to stage k+1 for treated individuals (k=1, 2, 3)





Infectivity of untreated individuals in stage k of infection (k=1, 2, 3, 4)
N0 330,000 Initial population size
ϵ 0.01 Infectivity of treated individuals
ω 0.5 Mixing parameter (ω=0 and ω=1 — assortative and proportionate mixing)
φ − ln[1− 5%/100%] year−1 Annual ART dropout rate
τ − ln[1− 30%/100%] year−1 Annual ART uptake rate
λ 0.1 Transmission probability per partnership
1−Ω 0.95 PrEP effectiveness
p 1 Fraction of PrEP users starting ART after HIV infection
ϵP h1/2 Infectivity of MSM on PrEP
l
P − ln[1− 95%/100%] year−1 Annual ART uptake rate for persons infected despite taking PrEP
K1/ loff 5 years Average duration of PrEP uptake
=K l, 3lon − ln[1− R/100%] year
−1
R∈ [0–80%]
Annual PrEP uptake rate
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is identical for both models, which in our analyses only happened when
HIV was eliminated by PrEP.
3. Results
The model with and without sexual trajectories were very similar in
terms of HIV transmission dynamics before the introduction of PrEP
intervention (see Fig. 3). In both models, the effective reproduction
number and the steady state HIV prevalence for different levels of ART
uptake were similar (Fig. 3A and B). More importantly, steady state
prevalence and population fractions at all risk levels were similar be-
tween the models as well (Fig. 3C and D). Departing from this baseline
scenario, we investigated the impact of sexual trajectories of MSM on
the reduction in HIV prevalence by PrEP.
Fig. 4 shows the contribution of sexual trajectories computed in the
way described in Section 2. In this figure we distinguished PrEP impact
on both overall (panel A) and risk level prevalence (panels B, C, and D).
For the overall prevalence, the contribution of sexual trajectories to
PrEP impact was always positive (Fig. 4A), which means that the in-
corporation of sexual trajectories into the model led to a higher re-
duction in the overall HIV prevalence by PrEP. For a time horizon of 5
to 40 years after PrEP introduction, the contribution of sexual trajec-
tories was between 0.4% and 5.2%. The largest contribution of sexual
trajectories (8.1%) was predicted for annual PrEP uptake of 10% in the
steady state. In the steady state, both models predicted zero contribu-
tion of sexual trajectories for PrEP uptake above 50%, because at this
level of PrEP uptake HIV was eliminated in the steady state in both
models. For PrEP uptake of between 20% and 80% the maximum
contribution was observed 40 years after PrEP initiation. These results
are explained by the fact that the model with trajectories ‘provides’
PrEP to MSM at middle and low risk levels, as they transit from high
risk level while taking PrEP. For a given level of PrEP uptake, the
number of individuals on PrEP at low and medium risk increases with
time. In the 40 years time horizon for PrEP uptakes of 10–80%, there
are dozens to hundreds of people at low and medium risk who take
PrEP due to behavior switch. In the model with trajectories the total
fraction of individuals on PrEP is 0.1–0.3% higher than in the model
without trajectories. Since there are many more individuals at low and
medium risk level than at high risk level, small changes at these risk
levels on HIV transmission risk can have a large impact on the overall
HIV prevalence. Therefore, the model with trajectories estimates a
larger impact on the overall prevalence than the model with fixed risk
Fig. 3. Dynamics of the models with and without sexual trajectories without PrEP. A and B show effective reproduction number and steady-state HIV prevalence for
different levels of annual ART uptake. C and D show steady-state prevalence and population fractions at low, medium and high risk levels without ART and at annual
ART uptake of 30%. In both models, prevalence in low and medium risk individuals was much lower than prevalence in high risk individuals. To be clearly visible in
one chart, in C we multiplied former prevalence by 10.
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levels in which only people at high risk level take PrEP. These in-
dividuals are only a small fraction of the entire population, hence big
changes at this risk level have little impact on the overall prevalence.
The contribution of sexual trajectories varied highly by risk level
(Fig. 4B–D. The contribution to PrEP impact among low risk individuals
(Fig. 4B) was negative in the first 15 years after PrEP introduction. At
longer times however, the contribution became positive and stayed like
that until the HIV epidemic reached the steady state. The model with
trajectories predicts a larger impact on HIV prevalence at low risk level
compared to the model without trajectories because in the former
model there are also PrEP users at low risk level while in the latter
model there are none. Since people stay on average long at each risk
level (about 15 years), this effect becomes visible only after 40 years.
The largest contribution of sexual trajectories to PrEP impact was seen
in the medium risk individuals (Fig. 4C). This contribution increased
with time and PrEP uptake up to the maximum of about 14.2% at 50%
PrEP uptake after 40 years. For uptake above 50% the contribution
dropped to zero in the steady state again because of HIV elimination.
The larger contribution of sexual trajectories to PrEP impact in the
medium risk individuals occurred because in the model with sexual
trajectories high risk PrEP users could decrease their risk behavior and
reduce HIV transmission within the medium risk individuals. For in-
dividuals at high risk, the contribution of sexual trajectories was posi-
tive but smaller than for individuals at medium risk (Fig. 4D). At high
risk level, in both models people take PrEP, but in the model without
trajectories people stay at high risk while in the model with trajectories
people on PrEP move to the medium and low risk level. Therefore, a
certain percentage of PrEP is ‘wasted’ to lower risk individuals, and
hence, the difference between the two models is smaller at high risk
level. This is also demonstrated with the decreasing line (yellow line)
for 40 years time horizon (i.e. more and more PrEP is provided to low
risk individuals instead of only high risk individuals in the model
without trajectories).
Although the contribution of sexual trajectories to PrEP impact
varied between risk levels, it never exceeded 15% for all parameter
values explored. In the main analyses, we assumed that every in-
dividual followed one of three linear sexual trajectories. However, in
real life people can have ‘relapses’ in higher or lower sexual risk be-
havior. Therefore, we performed sensitivity analyses (Fig. 5) to relax
the statement of linearity. We included four theoretical scenarios with
additional changes in sexual behavior of high risk individuals which
would increase the contribution of sexual trajectories on PrEP impact.
Fig. 4. Contribution of sexual trajectories to PrEP impact on HIV prevalence. Contribution of sexual trajectories was defined as the absolute difference between the
relative reduction in HIV prevalence in the model with sexual trajectories and the relative reduction in HIV prevalence in the model without sexual trajectories due to
PrEP. For both models, the relative reduction in prevalence measured in percentages was computed as (1− prevalence after PrEP/prevalence before PrEP)× 100%.
Positive/negative contribution of sexual trajectories indicates that PrEP impact on HIV prevalence is higher/lower in the model with sexual trajectories.
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The four arbitrarily chosen theoretical scenarios we considered were: (1)
reverse transition from medium to high risk along decreasing risk branch
(1/ν23,2=1/α32,2=15.1 years); (2) ten times slower changes in risk levels
along increasing risk trajectory (1/α12,1=10.1×10 years;
1/α23,1=7.6×10 years); (3) reverse transition from high to medium risk
level along increasing risk trajectory (1/ν32,1=1/α23,1=7.6 years);
(4) same as scenario 3 but with twice as fast reverse transition rate
(1/ν32,1=1/(2× α23,1)=7.6/2 years). In Fig. 5, we showed the con-
tributions of sexual trajectories in the four theoretical scenarios and in the
default scenario, for which we took data from Fig. 4. The contribution of
trajectories was calculated for 20% PrEP uptake after 40 years. In scenario
2, slower changes in risk behavior of individuals who increased risk during
their lifetime increased the contribution from 5.2% to 8.7%, when com-
pared to the baseline scenario. For scenarios 3 and 4 with reverse transi-
tions from high to medium risk, the contribution increased from 5.2% to
13.5% and 19.3%, respectively. In these cases, PrEP intervention was more
effective because fraction of individuals at medium risk became larger. In
addition, people at medium in the increasing risk trajectory could also take
PrEP. In scenario 1, where individuals experienced relapse in high risk
behavior in the decreasing risk trajectory, the contribution was marginally
larger (5.6%) than in the baseline scenario.
4. Discussion and conclusions
In this work, we studied the impact of long-term changes in sexual
risk behavior of MSM on the impact of PrEP on HIV prevalence by
comparing a mathematical model with fixed risk levels to a model
where MSM could change their behavior over their sexual lifetime.
These sexual trajectories represented slow changes in risk levels oc-
curring during an individual's life course. We found that the model with
sexual trajectories always predicted a larger impact of PrEP on the
overall HIV prevalence. The contribution of trajectories, however, was
rather modest and did not exceed 8.1%. Interestingly, the contribution
to PrEP impact at different risk levels varied depending on the time
after PrEP introduction and the level of PrEP uptake. The largest con-
tribution was predicted for PrEP impact on HIV prevalence at medium
risk level and after 40 years of PrEP intervention.
To our knowledge, this is the first study considering the impact of
long-term behavioral changes on HIV transmission dynamics and the
impact of PrEP. We used a unique data set with many years of long-
itudinal data to parameterize our model. Our model had several sim-
plifications. First, it focused on intrinsic long-term changes in sexual
risk behavior and did not incorporate short-term changes in behavior as
a result of PrEP use (also known as risk compensation (Stolte et al.,
2004; Bezemer et al., 2008; Jansen et al., 2011)). Second, in line with
the current guidelines (Ryom et al., 2016) we considered PrEP uptake
by high risk individuals while in reality individuals at medium and low
risk levels could be using PrEP too. However, we think that the direc-
tion of effect that we found (i.e. model with trajectories estimates a
larger impact of PrEP on HIV prevalence) will not be affected by this.
Third, PrEP uptake was assumed to be non-intermittent with an average
duration of 5 years. Other strategies for PrEP use such as PrEP on de-
mand in which individuals take preventive medication shortly before
and after high risk sexual behavior were shown to be effective for
preventing HIV infections as well (Molina et al., 2015). Again, we do
not think that adding this type of PrEP use in both models will change
the direction of the main results. Lastly, our model did not account for
many aspects of the partnership formation dynamics relevant for MSM.
In particular, we did not consider the effects of sero-sorting, partnership
concurrency and different degrees of assortative mixing. While these
factors might be important to evaluating PrEP impact in real-world
situations, neglecting them significantly simplified both models and
made their analyses tractable.
A larger impact of PrEP on HIV prevalence in the model with sexual
trajectories than in the model without sexual trajectories can mainly be
explained by the fact that people in the model with sexual trajectories
can move from high to medium risk level while on PrEP. As a con-
sequence, it is possible that people at medium risk level are also taking
PrEP. As the fraction of MSM at medium risk is relatively large com-
pared to the fraction of MSM at high risk, small changes in the medium
risk group transmission risk can have a larger impact on the overall HIV
prevalence compared to a model where PrEP use is only concentrated in
a small high risk group. However, this does not necessarily suggest that
PrEP should be given to individuals with medium risk, since this comes
down to cost-effectiveness analyses. Our developed model could be
extended further to study the impact of a time tailored PrEP interven-
tion. Targeting PrEP not only to high risk MSM but to specific periods of
high risk behavior during an individual's life course or designing in-
terventions that target MSM just before they enter a period of high risk
behavior could have a large impact on HIV transmission combined with
cost-effectiveness analyses.
We focused only on long-term changes in risk behavior and did not
account for fast changes in risk levels, such as episodic risk (Zhang et al.,
2012; Henry and Koopman, 2015). It was shown that the estimated impact
of universal test and treat control strategies is heavily influenced by epi-
sodic risk, making elimination of HIV impossible under certain circum-
stances. It is expected that this might also hold for other interventions such
as PrEP. Future work should focus on the impact of other types of beha-
vioural change on the estimated impact of PrEP on HIV prevalence such as
shorter changes in risk behavior or episodic risk.
Our study has implications for the interpretation of the estimated
impact of PrEP in other published modelling studies. Some of these
modelling studies, including two from the Netherlands (Nichols et al.,
2016; Rozhnova et al., 2018), did not incorporate behavior change in
the estimated impact of PrEP. Nichols et al. (2016) concluded that PrEP
rollout among high risk MSM would be cost-effective in the Nether-
lands. Rozhnova et al. (2018) concluded that large uptake of PrEP by
high risk MSM can lead to HIV elimination among the Dutch MSM. We
showed that a model that does not incorporate long-term behavioural
change underestimates the impact of PrEP on HIV prevalence, meaning
that the estimates from models that do not incorporate long-term
changes are conservative.
Fig. 5. Sensitivity analyses for the contribution of sexual trajectories to
PrEP impact in the extended model. The x-axis shows four theoretical sce-
narios: (1) reverse transition from medium to high risk along decreasing risk
trajectory; (2) ten times slower changes in risk levels along increasing risk
trajectory; (3) reverse transition from high to medium risk level along in-
creasing risk trajectory; (4) same as scenario 3 with twice as fast reverse
transition rate. The parameter values describing these scenarios are given in the
main text. The calculation of the contribution of sexual trajectories to PrEP
impact was done for 20% PrEP uptake after 40 years. For the baseline scenario
we took data from Figure 4.
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